Researcher
Eline Menu
- Research Expertise:
- Research for therapies, targeting the myeloma cell in its microenvironment
- Keywords:Medicine
- Disciplines:Hematology, Cell signalling, Cellular interactions and extracellular matrix, Cancer biology
- Users of research expertise:
- Research for therapies, targeting the myeloma cell in its microenvironment
Affiliations
- Hematology (Research group)
Member
From1 Oct 2001 → Today - Basic (bio-) Medical Sciences (Department)
Member
From1 Oct 2020 → Today - Basic (bio-) Medical Sciences (Department)
Member
From8 Apr 2019 → 30 Sep 2020 - Faculty of Medicine and Pharmacy (Faculty)
Member
From22 Jun 2017 → 7 Sep 2017 - Basic (bio-) Medical Sciences (Department)
Member
From1 Jan 2014 → 20 Oct 2022 - Basic (bio-) Medical Sciences (Department)
Member
From1 Jan 2014 → 30 Sep 2015 - Immunology and Microbiology (Department)
Member
From1 Nov 2009 → 31 Dec 2013 - Immunology and Microbiology (Department)
Member
From1 Oct 2001 → 31 Dec 2013
Projects
1 - 10 of 10
- SRP-Onderzoekszwaartepunt: PACT: multi-omics Profiling of T cells to improve Adoptive Cell TherapyFrom1 Nov 2022 → TodayFunding: BOF - projects
- Seahorse platform: the Agilent Seahorse Flux Analyser with integrated normalization systemFrom1 May 2020 → TodayFunding: Hercules - Small and Medium size research infrastructure
- Targeting the hypoxia-induced metabolic changes in multiple myeloma to conquer drug resistance.From1 Oct 2019 → 31 Jan 2024Funding: FWO fellowships
- advanced Metabolomics Platform consisting of two complementary LC-MS/MS analyzersFrom1 May 2016 → 30 Apr 2020Funding: Hercules - Small and Medium size research infrastructure
- Modulation of the tumor micro-environment in Multiple Myeloma, are exosomes involved?From1 Jan 2016 → 31 Dec 2019Funding: FWO research project (including WEAVE projects)
- Drug resistance in multiple myeloma: study of extrinsic mechanisms governed by the bone marrow microenvironmentFrom1 Jan 2014 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
- NKT cells as a target for treatment in Multiple MyelomaFrom1 Jan 2012 → 31 Dec 2014Funding: FWO research project (including WEAVE projects)
- Pre-clinical evaluation of NKT-cells in multiple myelomaFrom1 Jan 2011 → 31 Dec 2011Funding: FWO research grant KAN
- Tumor-microenvoronment interactions in multiple myeloma: regulation by epigenetic modifications and hypoxia.From1 Jan 2010 → 31 Dec 2013Funding: FWO research project (including WEAVE projects)
- The role of IGF-1 in Multiple Myeloma tumor progression: effects on cell cycle and UPR responseFrom1 Jan 2009 → 31 Dec 2009Funding: FWO research grant KAN
Publications
11 - 20 of 46
- Single-cell analysis at the protein level delineates intracellular signaling dynamic during hematopoiesis(2021)
Authors: Jinheng Wang, Chenggong Tu, Hui Zhang, Yongliang Huo, Eline Menu, Jinbao Liu
- A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma(2021)
Authors: Patrick Nylund, Alba Atienza Párraga, Jakob Haglöf, Elke De Bruyne, Eline Menu, Berta Garrido-Zabala, Anqi Ma, Jian Jin, Fredrik Öberg, Karin Vanderkerken, et al.
- Targeting phosphoglycerate dehydrogenase in multiple myeloma(2021)
Authors: Samah Elsaadi, Ida Steiro, Pegah Abdollahi, Esten Nymoen Vandsemb, Rui Yang, Tobias S Slørdahl, Torstein Baade Rø, Eline Menu, Anne Marit Sponaas, Magne Børset
- Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade(2020)
Authors: Rui Yang, Samah Elsaadi, Kristine Misund, Pegah Abdollahi, Esten Nymoen Vandsemb, Siv Helen Moen, Anna Kusnierczyk, Geir Slupphaug, Therese Standal, Anders Waage, et al.
- AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies(2019)
Authors: Siyang Yan, Niels Vandewalle, Nathan De Beule, Sylvia Faict, Ken Maes, Elke De Bruyne, Eline Menu, Karin Vanderkerken, Kim De Veirman
Pages: 1-17 - The Use of Murine Models for Studying Mechanistic Insights of Genomic Instability in Multiple Myeloma(2019)
Authors: Philip Vlummens, Kim De Veirman, Eline Menu, Elke De Bruyne, Fritz Offner, Karin Vanderkerken, Ken Maes
- Exosomal Communication in Multiple Myeloma: Friend or Foe(2019)
Authors: Sylvia Faict, Eline Menu
- The Epigenome in Multiple Myeloma(2018)
Authors: Eva De Smedt, Hui, Lui, Ken Maes, Kim De Veirman, Eline Menu, Karin Vanderkerken, Elke De Bruyne
- Epigenetic treatment of multiple myeloma mediates tumor intrinsic and extrinsic immunomodulatory effects(2018)
Authors: Lien De Beck, Sarah Melhaoui, Kim De Veirman, Eline Menu, Elke De Bruyne, Karin Vanderkerken, Karine Breckpot, Ken Maes
- Checkpoint inhibition in the treatment of multiple myeloma(2018)
Authors: Koen Venken, Mérédis Favreau, Djoere Gaublomme, Eline Menu, Karin Vanderkerken, Dirk Elewaut
Pages: 521-526